Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.
Fish oil beneficial for reducing risk for cardiovascular disease progression
May 22, 2024
However, supplements may be a risk factor for atrial fibrillation and stroke in the general population.
Physical activity time, step counts yield similar results
May 21, 2024
Similar benefits were seen for all-cause mortality and cardiovascular disease prevention.
Men face more diabetes complications than women
May 17, 2024
The findings were independent of diabetes duration over a 10-year period.
Plant-based diets tied to long-term health benefits
May 15, 2024
The benefits include a better cardiometabolic risk profile as well as lower mortality.
AI-informed health app aids diabetes outcomes
May 15, 2024
The app gives tailored nutrition and health recommendations, which are linked to decreases in HbA1c and heart disease risk.
Long-term study of postmenopausal women does not support many preventive therapies
May 02, 2024
Hormone therapy was no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation was no aid for universal fracture prevention.
Social determinants of health tied to atherosclerotic CVD risk
May 01, 2024
The authors say that social determinants could increase the prediction ability of risk tools, particularly for Black patients.
More medical lab tests will soon face federal scrutiny, FDA says
Apr 29, 2024
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by the US Food and Drug Administration, the agency announced Monday.